Skip to main content
Medical information Clinical review pending

Genetic Testing

West Nile Virus RNA Detection Qualitative Test

Detects the presence of West Nile Virus RNA in serum, plasma, or whole blood using Real Time PCR. Essential for diagnosing active WNV infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum, plasma, or whole blood.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking.
Test priceKSh 14,450

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the West Nile Virus RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of West Nile Virus (fever, headache, body aches, rash, neurological symptoms)
  • ✓Recent travel to areas with known WNV activity
  • ✓Exposure to mosquito populations known to carry WNV
  • ✓Monitoring for WNV in high-risk populations
  • ✓Diagnosis of neuroinvasive disease
02

In plain language

What this test helps you understand

Confirms an active West Nile Virus infection by detecting viral RNA. Aids in clinical management and helps prevent complications.
The West Nile Virus RNA Detection Qualitative Test is a diagnostic tool used to identify the presence of West Nile Virus (WNV) in patients. This test is particularly important in regions where WNV is prevalent, as early detection can significantly influence treatment outcomes. Utilizing the advanced method of Real Time PCR, this test provides rapid and accurate results, ensuring timely intervention for patients.

This qualitative test specifically detects the RNA of the West Nile Virus in various sample types, including serum, plasma, and whole blood. By identifying the viral RNA, healthcare providers can confirm an active infection, which is crucial for appropriate clinical management.

Individuals who may be at risk of West Nile Virus infection should consider this test. Common symptoms include fever, headache, body aches, joint pain, rash, and neurological symptoms in severe cases. Additionally, individuals who have recently traveled to areas with reported cases of WNV or who have been in contact with infected mosquitoes should also consider testing.

Benefits of taking this test include early diagnosis leading to timely treatment, accurate detection of viral RNA for reliable results, help in managing symptoms effectively and preventing complications, and providing peace of mind for patients and their families.

Results from the test will indicate whether the virus is present in your system. A positive result confirms an active infection, while a negative result suggests that the virus is not currently detectable. It is important to discuss your results with your healthcare provider to understand the next steps in your care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking.
SampleSerum, plasma, or whole blood.
MethodologyReal Time PCR (Polymerase Chain Reaction)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects viral RNA, indicating an active infection. It may not detect past infections. Results can be affected by sample quality and timing of collection relative to symptom onset. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the genetic material (RNA) of the West Nile Virus in your blood sample.
A blood sample will be collected from your arm.
Turnaround time varies. Please contact the laboratory for specific details.
A positive result indicates that the West Nile Virus RNA was detected in your sample, suggesting an active infection.
If you have symptoms suggestive of West Nile Virus, consult your healthcare provider immediately.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp